AK
Amod Kumar Mishra
About Amod Kumar Mishra
Amod Kumar Mishra has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Lifesyntez Pharma Private Limited and Iatric Lifescience Private Limited. Formerly with 3 companies, such as Chemerix Biotech Private Limited and Camus Pharma Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Iatric Lifescience Private Limited
U24304TG2017PTC118095
|
Director | 05 Jul 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Chemerix Biotech Private Limited
U24304TS2017PTC202075
|
Director | 30 Mar 2018 | 2017 | Active |
Camus Pharma Private Limited
U24232RJ1997PTC013970
|
Director | 16 Aug 2016 | 1997 | Active |
Lifesyntez Pharma Private Limited
U24232RJ2015PTC047157
|
Director | 30 Mar 2018 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amod Kumar Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amod Kumar Mishra
Amod Kumar Mishra has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Lifesyntez Pharma Private Limited and Iatric Lifescience Private Limited. Formerly with 3 companies, such as Chemerix Biotech Private Limited and Camus Pharma Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Amod Kumar Mishra is associated with 1 company as Director.
Amod Kumar Mishra has expertise in General Business, Technology.
Amod Kumar Mishra has 9 years in corporate governance.